| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NANOSTRING TECHNOLOGIES INC | 3,959,440 | 58,243,000 | 40.82% | ||
| 2 | Oxford Immunotec Global PLC | 2,153,092 | 24,761,000 | 17.35% | ||
| 3 | Catabasis Pharmaceuticals Inc | 2,752,488 | 21,827,000 | 15.30% | ||
| 4 | SIENTRA INC | 2,730,765 | 16,166,000 | 11.33% | ||
| 5 | VBI Vaccines Inc. | 4,971,091 | 12,129,000 | 8.50% | ||
| 6 | TETRALOGIC PHARMA CO | 4,644,705 | 8,035,000 | 5.63% | ||
| 7 | AERIE PHARMACEUTICALS INC | 63,017 | 1,534,000 | 1.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-16-000929, filed 2016.01.25).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
